MAM
TSVT

Martingale Asset Management’s 2seventy bio TSVT Stock Holding History

Martingale Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,500
Closed -$45.6K – 830
2024
Q4 		$45.6K Sell
15,500
-42,658
-73% -$175K ﹤0.01% 756
2024
Q3 		$275K Hold
58,158
– – 0.01% 720
2024
Q2 		$224K Buy
58,158
+13,000
+29% +$58.6K ﹤0.01% 743
2024
Q1 		$242K Buy
+45,158
New +$212K ﹤0.01% 742
2023
Q4 		– Sell
-61,995
Closed -$243K – 849
2023
Q3 		$243K Buy
+61,995
New +$407K 0.01% 722

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Martingale Asset Management's TSVT Position: Q1 2025 in Review

Martingale Asset Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 15,500 shares — an estimated $45.6K sold.

Martingale Asset Management first reported a position in TSVT in Q3 2023 and held it in 5 quarters. The position peaked at $275K in Q3 2024. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Martingale Asset Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Martingale Asset Management sold 15,500 2seventy bio shares in Q1 2025, an estimated $45.6K.
  • Martingale Asset Management first reported a position in 2seventy bio in Q3 2023 and held it in 5 quarters.
  • Martingale Asset Management's 2seventy bio position peaked at $275K in Q3 2024.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Martingale Asset Management's 13F filing for Q1 2025, filed 14 May 2025.